Filing Details
- Accession Number:
- 0001179110-20-003589
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-12 19:01:16
- Reporting Period:
- 2020-03-10
- Accepted Time:
- 2020-03-12 19:01:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1292519 | Invivo Therapeutics Holdings Corp. | NVIV | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247224 | Ann C Merrifield | C/O Invivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-10 | 3,636 | $0.00 | 3,639 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant (right to buy) | Acquisiton | 2020-03-10 | 3,636 | $0.00 | 3,636 | $2.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,636 | 2020-03-10 | 2025-03-10 | No | 4 | P | Direct |
Footnotes
- The reported securities were sold together at a combined purchase price of $2.75 per share of common stock and warrant to purchase one share of common stock.